Variant report
Variant | nsv1020129 |
---|---|
Chromosome Location | chr5:98582211-98631295 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140863912 | chr5:98582214-98582215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs115121854 | chr5:98582223-98582224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs149747069 | chr5:98582285-98582286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537826069 | chr5:98582300-98582301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550507990 | chr5:98582414-98582415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568802652 | chr5:98582579-98582580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145434922 | chr5:98582727-98582728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78559875 | chr5:98582800-98582801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148822909 | chr5:98582808-98582809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs181504328 | chr5:98582827-98582828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186455973 | chr5:98582839-98582840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs72777471 | chr5:98582852-98582853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs77583919 | chr5:98582857-98582858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190484496 | chr5:98582858-98582859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575137424 | chr5:98582870-98582871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571890304 | chr5:98582879-98582880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554339941 | chr5:98582886-98582887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542460497 | chr5:98582887-98582888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs6596776 | chr5:98582895-98582896 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs527861358 | chr5:98582916-98582917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78677777 | chr5:98582928-98582929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181042911 | chr5:98582974-98582975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs145286689 | chr5:98583014-98583015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs531640918 | chr5:98583016-98583017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs77013196 | chr5:98583020-98583021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531720303 | chr5:98583066-98583067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs58402973 | chr5:98583069-98583070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558260944 | chr5:98583114-98583115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549947729 | chr5:98583151-98583152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs35530575 | chr5:98583167-98583168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs73137726 | chr5:98583222-98583223 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs532639934 | chr5:98583229-98583230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs73776749 | chr5:98583252-98583253 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs116682800 | chr5:98583256-98583257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566685981 | chr5:98583276-98583277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs58485837 | chr5:98583279-98583280 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs558657646 | chr5:98583302-98583303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533773018 | chr5:98583379-98583380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs370585296 | chr5:98583431-98583432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186078911 | chr5:98583455-98583456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs556163601 | chr5:98583466-98583467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs575233923 | chr5:98583468-98583469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs137928011 | chr5:98583469-98583470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs554155001 | chr5:98583506-98583507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375529844 | chr5:98583557-98583558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577505403 | chr5:98583565-98583566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs373984364 | chr5:98583575-98583576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs74423025 | chr5:98583591-98583592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs564607496 | chr5:98583640-98583641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs531652506 | chr5:98583644-98583645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:98579200-98582800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:98582800-98584000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr5:98583000-98583600 | Enhancers | Fetal Muscle Leg | muscle |
4 | chr5:98583400-98584200 | Enhancers | HUVEC | blood vessel |
5 | chr5:98584000-98584400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr5:98584400-98584800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr5:98589400-98592400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr5:98591200-98591800 | Active TSS | Primary T helper memory cells from peripheral blood 1 | blood |
9 | chr5:98592400-98593000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr5:98593000-98593200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr5:98615200-98615600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr5:98621600-98622000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |